Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
AAKAAR

Aakaar Medical Technologies Share Price

 

 

Aakaar Medical Technologies live price: ₹66.2. It opened at ₹63 vs previous close ₹60; intraday high/low: ₹63/₹63. The 50 & 200 DMA stand at ₹57.38/₹72.44.

Aakaar Medical Technologies Performance

  • Today's Low
  • ₹63
  • Today's High
  • ₹63
  • 52 Week Low
  • ₹46
  • 52 Week High
  • ₹105
  • Open Price₹63
  • Previous Close₹60
  • Volume1,600
  • 50 DMA₹57.38
  • 100 DMA₹61.54
  • 200 DMA₹72.44

Aakaar Medical Technologies Chart

Investment Returns

  • Over 1 Month + 10.33%
  • Over 3 Month -8.94%
  • Over 6 Month -14.25%
  • Over 1 Year -8.06%

Smart Investing Starts Here Start SIP with Aakaar Medical Technologies for Steady Growth!

Invest Now

Aakaar Medical Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 94
  • P/B Ratio
  • 2
  • Average True Range
  • 2.62
  • EPS
  • 4.68
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.2
  • RSI
  • 68.3
  • MFI
  • 46.86

Aakaar Medical Technologies Financials

Aakaar Medical Technologies Technicals

EMA & SMA

Current Price
₹66.20
+ 3.15 (5%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹57.18
  • 50 Day
  • ₹57.38
  • 100 Day
  • ₹61.54
  • 200 Day
  • ₹72.44

Resistance and Support

66.2 Pivot Speed
  • R3 66.20
  • R2 66.20
  • R1 66.20
  • S1 66.20
  • S2 66.20
  • S3 66.20

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aakaar Medical Technologies Ltd. distributes advanced laser, RF, and ultrasound devices for aesthetic and medical use. it serves clients across India, offering skincare, haircare, and bodycare solutions backed by innovative technology and expert support.

Aakaar Medical Technologies Ltd has an operating revenue of Rs. 156.25 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 14% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and around 12% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 96 which is a GREAT score indicating consistency in earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aakaar Medical Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-25 Others To consider Other business matters (Re-Scheduled)
2026-05-15 Audited Results & Others To consider Other business matters.
2025-11-10 Quarterly Results

Aakaar Medical Technologies Shareholding Pattern

67.05%
0%
15.99%
16.96%

Aakaar Medical Technologies FAQs

Aakaar Medical Technologies share price is ₹66 As on 22 May, 2026 | 02:04

The Market Cap of Aakaar Medical Technologies is ₹93.8 Cr As on 22 May, 2026 | 02:04

The P/E ratio of Aakaar Medical Technologies is 14.1 As on 22 May, 2026 | 02:04

The PB ratio of Aakaar Medical Technologies is 2 As on 22 May, 2026 | 02:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23